UK scientists have discovered that a widely-available anti-inflammatory drug can reduce deaths in COVID-19 patients on ventilation by a third.
More than half a million doses of the Oxford/AstraZeneca vaccine are available today, with tens of millions more to be delivered in the coming weeks.